Baseline characteristics of patients with T2DM, and patients who received insulin
| T2DM cohort (n=73 819) | Patients with T2DM with insulin during follow-up (n=9969) | ||
| Gender, n (%) | Male | 40 521 (54.9) | 5277 (52.9) |
| Female | 33 298 (45.1) | 4692 (47.1) |
| Age at first glucose-lowering medication use (index date) | Age at first insulin use | ||
| Age, n (%) | 45–55 y | 17 444 (23.6) | 2640 (26.5) |
| 56–65 y | 21 816 (29.6) | 2800 (28.1) | |
| ≥66 y | 34 559 (46.8) | 4529 (45.4) |
T2DM, type 2 diabetes mellitus.